no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation
|
Oka, Satoru |
|
2017 |
17 |
3 |
p. 389-396 |
article |
2 |
A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis
|
Homma, Koichiro |
|
2017 |
17 |
3 |
p. 397-402 |
article |
3 |
A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma
|
Sho, Takuya |
|
2017 |
17 |
3 |
p. 381-388 |
article |
4 |
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
|
Muggeri, Alejandro |
|
2017 |
17 |
3 |
p. 427-434 |
article |
5 |
Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study
|
Guitart, Jordi |
|
2017 |
17 |
3 |
p. 419-425 |
article |
6 |
Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
|
Rascati, Karen |
|
2017 |
17 |
3 |
p. 487-488 |
article |
7 |
Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus
|
Nishida, Yayoi |
|
2017 |
17 |
3 |
p. 403-412 |
article |
8 |
Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada
|
Kuribayashi, Ryosuke |
|
2017 |
17 |
3 |
p. 371-379 |
article |
9 |
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
|
Skor, Heather |
|
2017 |
17 |
3 |
p. 449-459 |
article |
10 |
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
|
Grassi, Paolo |
|
2017 |
17 |
3 |
p. 461-467 |
article |
11 |
Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study
|
Vergara-Dangond, Cristina |
|
2017 |
17 |
3 |
p. 481-485 |
article |
12 |
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
|
Galiana, Graciana L. |
|
2017 |
17 |
3 |
p. 329-339 |
article |
13 |
Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction
|
Egusa, Kenji |
|
2017 |
17 |
3 |
p. 413-418 |
article |
14 |
Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region
|
Dagenais, Renée |
|
2017 |
17 |
3 |
p. 341-361 |
article |
15 |
Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant
|
Hanada, Kazuhiko |
|
2017 |
17 |
3 |
p. 475-480 |
article |
16 |
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
|
Webb, David J. |
|
2017 |
17 |
3 |
p. 441-448 |
article |
17 |
Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine
|
Young, Tramaine |
|
2017 |
17 |
3 |
p. 435-440 |
article |
18 |
Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist
|
Toyama, Kaoru |
|
2017 |
17 |
3 |
p. 363-370 |
article |
19 |
Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies
|
Gojo, Johannes |
|
2017 |
17 |
3 |
p. 469-474 |
article |